Associate Professor of Medicine, UCSD
Gastroenterology
Dr. Rohit Loomba, MD
|
|
Give Review
Rohit Loomba is an expert in the field of Gastroenterology. He studied medicine at Armed Forces Medical College Pune. He received awards:"Health Heros Award" and "CMS Meaningful Use Stage 1 Certification". Rohit Loomba is a published doctor. He published 50 publications, including: 'Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients.' He is registered with Medicare.
Publications
- Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis.
- Caring for children with NAFLD and navigating their care into adulthood.
- MRE is superior to ARFI for the diagnosis of fibrosis in patients with biopsy-proven NAFLD: A prospective study.
- Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
- Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel MRI and MRE in a randomized trial (MOZART Trial).
- Editorial: NAFLD in HIV infection--call for action. Authors' reply.
- Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study.
- Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
- Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis.
- The TM6SF2 Variants, Novel Genetic Predictors for Nonalcoholic Steatohepatitis.
- Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study.
- Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
- Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults.
- Effect of Weight Loss on MRI Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis.
- Supplementation of Saturated Long-chain Fatty Acids Maintains Intestinal Eubiosis and Reduces Ethanol-induced Liver Injury in Mice.
- Hepatocellular Carcinoma Surveillance: A National Survey of Current Practices in the USA.
- Cross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitis.
- Rationale for conducting randomized trial to examine the efficacy of metformin in improving survival in cirrhosis: Pleiotropic effects hypothesis.
- State of the art: treatment of nonalcoholic steatohepatitis.
- Fibrosis Progression in Nonalcoholic Fatty Liver versus Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies.
- Serum alanine aminotransferase as a biomarker of treatment response in nonalcoholic steatohepatitis.
- Commentary: dissecting the PNPLA3 association with liver fat and stiffness, and interaction with diet.
- Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease.
- Effect of echo-sampling strategy on the accuracy of out-of-phase and in-phase multiecho gradient-Echo MRI hepatic fat fraction estimation.
- Longitudinal comparison between MRI, MRS and histology-determined steatosis in NAFLD patients at two-time points in a randomized trial.
- Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects.
- The global NAFLD epidemic.
- TGF-β signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism.
- Null association between abdominal muscle and calcified atherosclerosis in community-living persons without clinical cardiovascular disease: The multi-ethnic study of ...
- Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.
- Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.
- Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma.
- Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum...
- Transforming Growth Factor-? Signaling in Hepatocytes Promotes Hepatic Fibrosis and Carcinogenesis in Mice with Hepatocyte-Specific Deletion of TAK1.
- Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis.
- Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes.
- Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.
- Hepatitis B virus management to prevent reactivation after chemotherapy: a review.
- Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial.
- Society of interventional radiology critique and commentary on the cochrane report on transarterial (chemo)embolisation.
- Commentary: new tools to assess hepatic steatosis - what do we want to measure? Author's reply.
- Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic s...
- Association between diabetes, family history of diabetes and risk of nonalcoholic steatohepatitis and fibrosis.
- Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins.
- The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis.
- Novel approaches to new therapies for hepatitis B virus infection.
- Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls.
- Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients.
- Targeting Dysbiosis for the Treatment of Liver Disease.
Doctors Specialties
- Internal Medicine
- Gastroenterology
Accepted Insurances
Awards
- Health Heros Award
- CMS Meaningful Use Stage 1 Certification
Education
-
University of California San Diego -
National Institutes of Health Clinical Center -
Armed Forces Medical College Pune
Hospital
-
UC San Diego Health
Helpful Reviews
Similar Doctors
|
|
Dr. Tonia B. Vyenielo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah L. Steinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanne P. Keenan, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kan P. Chen, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Celestine Arambulo, DO |
|
|
Dr. Von A. Ta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arnold R. Yalam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vivian H. Tso, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Foss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew R. Bruggeman, MD |
|
|
Dr. Eric M. David, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce L. Zuraw, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michael T. Bennett, MD |
|
|
Dr. Michael Goldhamer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William W. Shields, DO |
|
|
Dr. Gordon C. Hunt, MD |
|
|
Dr. Sally B. Stipho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carrie Wong, MD |